GeDP PHARMA
ActiveSummary
GeDP PHARMA has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €73,280 and a net result of €36,166. Equity is growing by about 71% per year across the filed financial years. Its solvency ranks better than 16% of 12,678 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
19-06
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2025
31-12
Financial
Highest result from 2023 to 2025net €36,166 ▲115%
Net result €36,166, the highest in the series.
13-06
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
30-06
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
14-06
Gazette deed
IncorporationAppointment: DEPOORTER Géraldine Dominique Marie-Paule Alicia (director) · Founding capital · Founder11 facts ▸
Gazette deed
Incorporation
Appointment: DEPOORTER Géraldine Dominique Marie-Paule Alicia (director) · Founding capital · Founder11 facts ▸
- Other provision, “bekwaamheid comparant” (deed in Dutch)
- Other provision, “toelichting akte” (deed in Dutch)
- Other provision, “voorlezing erkenning” (deed in Dutch)
- Other provision, “voorlezing afstand” (deed in Dutch)
- Incorporation, “GeDP PHARMA” (deed in Dutch)
- Founding capital, €10,000
- Founder, DEPOORTER Géraldine Dominique Marie-Paule Alicia
- Other provision, 16-05-2023
- Registered office clause, “8300 Knokke-Heist,De Vrede, neerlegging ter griffie van uitgifte” (deed in Dutch)
- Board rule, 1, “neerlegging ter griffie van uitgifte” (deed in Dutch)
- Director appointment, DEPOORTER Géraldine Dominique Marie-Paule Alicia (director (not named in the articles))
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 1 deed read